|
Cancer is the leading cause of death for adults in the United States.
At Tocagen, we believe that no one should die of cancer. We believe cancer patients can achieve long-term remission and many may be cured.
Tocagen is initially focusing on treatments for terminally ill cancer patients for whom no adequate treatment currently exists.
The founding technology of the Company is a novel replicating gene transfer platform, which we believe will be more effective, with fewer side effects, than many current conventional cancer treatments.
Read more about how Tocagen's scientists have created breakthrough technology for the treatment of cancer.
|
